Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 4Observational 2

Sponsor

Conditions

Breast Neoplasms 2234Neoplasms 2039Lung Neoplasms 1097Colorectal Neoplasms 1036Prostatic Neoplasms 894Carcinoma, Non-Small-Cell Lung 752Carcinoma, Hepatocellular 674Stomach Neoplasms 607Pancreatic Neoplasms 602Head and Neck Neoplasms 434Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 347Brain Neoplasms 329Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 304Precursor Cell Lymphoblastic Leukemia-Lymphoma 293Urinary Bladder Neoplasms 290Leukemia, Myeloid, Acute 278Lymphoma 268Liver Neoplasms 253Endometrial Neoplasms 253Hematologic Neoplasms 252Disease 244Recurrence 225Glioma 218Carcinoma, Renal Cell 207

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Observational × Drug Resistant Epilepsy × Clear all
NCT06724029 2026-03-30

NEON

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Recruiting
4,500 enrolled

Drug Resistant Epilepsy, Aneurysm, Arteriovenous Malformations, Depression, Facial Pain, Hematoma, Subdural, Hydrocephalus, Hydrocephalus, Normal Pressure, Moyamoya Disease, Muscle Spasticity, Neuralgia, Obsessive-Compulsive Disorder, Subarachnoid Hemorrhage, Tremor, Trigeminal Neuralgia, Dystonic Disorders, Hematoma, Epidural, Spinal

NCT05469373 2025-12-23

ESIS in Pediatric DRE

Children's Hospital Medical Center, Cincinnati

Recruiting
86 enrolled

Drug Resistant Epilepsy, Epilepsy, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡